Company intelligence / Profile preview

Changzhou Institute of Pharmaceutical Research

Changzhou, Jiangsu, China

Ownership: Private
Employees: ~240
Development stage: Other

Overview

Changzhou Institute of Pharmaceutical Research is an innovative high-tech enterprise specializing in R&D, production, and sales of medical device products, with notable research in sodium hyaluronate gel and collaboration with leading academics. Its products are commercialized.

Therapeutic areas: DermatologyOphthalmologyRheumatology
Modalities: Medical device materialsBiologicSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

Institute of Natural and Medical Sciences, University of Tubingen (collagen laboratory)School of Materials Science and Technology, Tsinghua University (spider silk protein research)

Beyond the preview

Go deeper on Changzhou Institute of Pharmaceutical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changzhou Institute of Pharmaceutical Research.

Explore the full profile